Rheumatoid factor and anti-cyclic citrullinated peptides were found in a high proportion of patients with palindromic rheumatism. The clinical features of the disease in our study were different in rheumatoid factor and anti-cyclic citrullinated peptide positive and negative patients.
A 24-h urinary protein is a standard way to diagnose lupus nephritis. Assessment of protein-creatinine (Pr-Cr) ratio in morning spot urine is a valuable method in diabetic patients but not use in systemic lupus erythematous (SLE) patients routinely. In this study Pr-Cr ratio in spot urine was compare with 24-h urine protein; if they have valuable correlation we can use this test instead of 24-h urinary protein. The aim of this study was to evaluate the correlation of spot urine Pr-Cr ratio for prediction of significant proteinuria (>or=300 mg/24 h) in patients with SLE. A cross-section study was conducted in 74 hospitalized women with SLE. The correlation between Pr-Cr in first morning urine specimens and urinary protein excretion in 24-h collections were analyzed. Correlation between Pr-Cr ratio in spot morning urine specimens and urinary protein excretion in 24-h collections was significant (P < 0.0001, r = 0.83). A high correlation and precision of agreement were demonstrated between the two methods of assessment proteinuria in lupus patients. The difference between the two methods was less than the biological variability in the protein excretion and its measurement, enabling the methods to be used interchangeably creatinine ratio in spot morning urine samples is a precise indicator of proteinuria in patients with lupus nephritis and represents a simple and inexpensive procedure in establishing severity of proteinuria in patients with SLE.
Background
Macrophages play a crucial role in the pathogenesis of rheumatoid arthritis (RA). Growth differentiation factor‐15 (GDF‐15) acts as an autocrine regulator of macrophage activation. Objective: The aim of this study was to assess serum level of GDF‐15 as a potential biomarker for detecting RA activity.
Method
A total of 100 female RA patients and 55 age and weight matched healthy control females were enroled. The serum level of GDF‐15 was measured using enzyme‐linked immunosorbent assay.
Results
Serum levels of GDF‐15 in RA patients with high, moderate, low and no disease activity were 989.0 ± 161.9, 505.6 ± 220.5, 349.2 ± 155.9 and 349.0 ± 144.0 pg/mL, respectively. GDF‐15 with a cut‐off value higher than 705 pg/mL was indicative of high RA activity with sensitivity of 96% and specificity of 92%.
Conclusion
GDF‐15 serum levels may be used as a biomarker to predict high RA disease activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.